Data as of Oct 17
| -0.01 / -0.25%|
The 6 analysts offering 12-month price forecasts for TherapeuticsMD Inc have a median target of 10.00, with a high estimate of 34.00 and a low estimate of 7.00. The median estimate represents a +151.89% increase from the last price of 3.97.
The current consensus among 5 polled investment analysts is to Buy stock in TherapeuticsMD Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.